west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "WU Yigen" 2 results
  • New Progress in TNM Staging of Lung Cancer

    The TNM staging of lung cancer which is now widely used in clinic was formally proposed in 1997. It has played quite an important role in directing the diagnosis and treatment of lung cancer as well as the clinical research in the past decade. However, at the same time, there are some insufficiencies which are emerging gradually. By collecting the clinical information from 100 869 patients, in 2007, International Association for the Study of Lung Cancer(IASLC) made a deep analysis on the relativity between TNM staging and prognosis, and put forward the suggestions to revise the Seventh Edition of the TNM staging of lung cancer: (1) According to the size of tumor, the primary T staging is divide into T1a (the maximum tumor diameter≤2 cm), T1b (3 cm≥the maximum tumor diameter>2 cm), T2a (5 cm≥the maximum tumor diameter>3 cm) and T2b (7 cm≥the maximum tumor diameter>5 cm); (2) T 2c (the maximum tumor diameter gt;7 cm) and additional nodules in the same lobe are classified as T3, while nodules in the ipsilateral nonprimary lobe are classified as T4;(3) Cancerous hydrothorax, pericardial effusion and the additional nodules in the contralateral lung are classified as M1a, while the extrapulmonary metastases are classified as M1b. It is believed that the new revised edition will has higher international authority and identification degree, and it will play a more meticulous and accurate guiding role in the treatment of lung cancer and its predicting prognosis in the future. At the same time, it will provide a new starting point to the research of lung cancer. 

    Release date:2016-08-30 06:06 Export PDF Favorites Scan
  • Effects of Ischemic Postconditioning on Inflammatory Response in Ischemia-Reperfusion Injury of Rat Lungs in Vivo

    Objective To investigate the effects of ischemic postconditioning (IPO) on inflammatory response inischemia-reperfusion (IR) injury of rat lungs in vivo. Methods Forty SD rats were randomly divided into 5 groups inclu-ding a sham surgery group (S group),a 30-minute IR group (I/R-30 group),a 120-minute IR group(IR-120 group),a 30-minute IPO group (IPO-30 group),and a 120-minute IPO group (IPO-120 group). There were 8 rats in each group. All therats received left thoracotomy after anesthesia. In the sham surgery group,a line was only placed around the left hilum butnot fastened. In the I/R-30 group and I/R-120 group,a line was fastened to block the blood flow of the left lung for 1 hour,then loosened for reperfusion for 30 minutes and 120 minutes respectively. In the IPO-30 group and IPO-120 group,afterblocking the blood flow of the left lung for 1 hour,the left hilum was fastened for 10 seconds and loosened for 10 seconds(repeating 3 times for 1 minute),then the line was loosened for 30 minutes and 120 minutes respectively. The levels of interleukin-10 (IL-10) in lung tissues and soluble intercellular adhesion molecule-1 (sICAM-1) in plasma were measured. Histopathological changes of lung tissues were observed and diffuse alveolar damage (DAD) scores was calculated.Results The levels of plasma sICAM-1 in the I/R-30 group and I/R-120 group were significantly higher than that of S group [(2.140±0.250)μg/L vs. (0.944±0.188)μg/L,P=0.003;(2.191±0.230)μg/L vs. (0.944±0.188)μg/L,P=0.003]. IL-10levels in lung tissues in the I/R-30group and I/R-120 group were also significantly higher than that of S group[(15.922±0.606)pg/mg pro vs. (7.261±0.877)pg/mg pro,P=0.037;(17.421±1.232)pg/mg pro vs. (7.261±0.877)pg/mg pro,P=0.042]. Pathologic lesions of lung tissues in the I/R-30 group and I/R-120 group were more severe than that of S group. After IPO, plasma sICAM-1 levels in the IPO-30 group and IPO-120 group were significantly lower than those in the I/R-30group and I/R-120 group respectively [(1.501±0.188)μg/L vs.(2.140±0.250)μg/L,P=0.038;(1.350±0.295)μg/L vs.(2.191±0.230)μg/L,P=0.005]. IL-10 levels in lung tissues in the IPO-30 group and IPO-120 group were significantly higherthan those in the I/R-30 group and I/R-120 group respectively [(20.950±1.673)pg/mg pro vs.(15.922±0.606)pg/mgpro,P=0.008;(25.334±1.173)pg/mg pro vs.(17.421±1.232)pg/mg pro,P=0.006]. DAD scores in the IPO-30 group andIPO-120 group were significantly lower than those in the I/R-30 group and I/R-120 group respectively [6.8±1.4 vs. 11.5±1.9,P=0.007;7.5±1.6 vs. 13.2±1.7,P=0.005]. Pathological lesions of the lung tissues of IPO groups were less severe than those of I/R groups. Conclusion IPO can attenuate IR injury by inhibiting inflammatory response in rat lungs.

    Release date:2016-08-30 05:47 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content